Across TCGA pan-cancer cohorts, OR8F1P RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of OR8F1P’s most consistent transcriptional readouts.
The strongest signal is observed in stomach adenocarcinoma (STAD), where OR8F1P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types OR8F1P is over-expressed in tumor.
STAD are the cancer types where OR8F1P tumor–normal differential expression is most reproducible.